Milestones for

Increased operator awareness can be prompted by use of rate of process variable change, at absolute process variable milestones. For example, devices can indicate or be set to alarm if the rate of temperature rise is 5°C/minute for the 10 minutes preceding a process temperature of 100°C. 

In general, there are three milestones for the drug discovery process. The first is the identification of a verified hit series (primary activity in a related series of molecules), the second the determination of a lead series (series with primary activity and drug-like properties), and the third a clinical candidate (activity, positive pharmaceutical, and pharmacokinetic properties devoid of toxicity). An example... 

The discovery of the decay chain, of course, started with the seminal work of Marie Curie in identifying and separating Ra. Through the work of the Curies and others, all the members of the decay chain were identified. An important milestone for geochronometrists was the discovery of °Th (called Ionium) by Bertram Boltwood, the Yale scientist who also made the first age determinations on minerals using the U-Pb dating method (Boltwood in 1906 established the antiquity of rocks and even identified a mineral from Sri Lanka-then Ceylon as having an age of 2.1 billion years )... 

The completion of this volume marks the happy milestone for me of a 15-year editorial association with Academic Press. It is appropriate, therefore, to acknowledge the professionalism of the staff and management, as well as their manifold contributions to the success of these volumes. It also marks my embarkation on new and more challenging professional pursuits. These ultimately will allow more opportunity to continue to perform the editorial tasks associated with Advances in Clinical Chemistry, as well as other educational and scientific activities. 

Chiral amines were always considered important targets for synthetic chemists, and attempts to prepare such compounds enantioselectively date back to quite early times. Selected milestones for the development of enantioselective catalysts for the reduction of C = N functions are listed in Table 34.1. At first, only heterogeneous hydrogenation catalysts such as Pt black, Pd/C or Raney nickel were applied. These were modified with chiral auxiliaries in the hope that some induction - that is, transfer of chirality from the auxiliary to the reactant -might occur. These efforts were undertaken on a purely empirical basis, without any understanding of what might influence the desired selectivity. Only very few substrate types were studied and, not surprisingly, enantioselectivities were... 

Table 34.1 Selected milestones for the enantioselective hydrogenation of C = N functions.

Melatonin receptor agonists and their relevance for the treatment of sleep disorders and major depression have been previously reviewed in Ann. Rep. Med. Chem., volume 39 [29]. Since then, ramelteon has been approved, representing an important milestone for the proof of concept of this target, and has opened new possibilities for research. 

Subsequent to the extensive medicinal chemistry exploration of Orexin antagonism, its utility in the treatment of sleep disorders in man has been reported recently. This important milestone for the therapeutic validation of the target results from the 0X1 /OX2 receptor antagonist ACT-078573 (20) [57], SB-649868 has also been announced to be in phase II clinical development, but neither the structural formula nor the results have been reported to date [58,59]. Moreover, insomnia treatments based on orexin modulation may be addressed by not only receptor antagonism but by inhibition of pathways related to the genesis of the bioactive peptides Orexin A or B, e.g. inhibition of Orexin-converting enzyme [60]. 

The cure is to use RAD-style timeboxing Put developers under a lot of stress to produce something demonstrably fast, with milestones for the specs and other documentation to get in sync. 

Additional developmental milestones for FPOP include the demonstration of fCd determination and development of dose-dependent radical foot printing by using different scavengers and concentrations to vary and then quantify the loss of unmodified peptide signal and the increase of modified peptide. Further advances can be made by determining with certainty the reaction timescale. At the... 

Achieving the break-even point in the 3rd quarter of 2007 is an important milestone for ChemKit. Exceeding the break-even point will show that the business policy and range of services finds acceptance in the domestic market and that ChemKit is already able to carry out enough projects to cover all costs and earn additional profits. 

The book is intended as a milestone for the field, documenting progress and serving as a reference source for many years to come. 

During the design, specify and procure stage, preliminary process control and implementation plans are developed. These plans lay out the basic timing/milestones for each effort, as well as define the roles necessary to complete all the given tasks. It is expected... 

Figure 3.1 Hypothetical drug development pipeline, illustrating activities during a 12-month period. Three stages of drug development are indicated at the bottom of the figure. The corresponding milestones for each stage are indicated at the top of the figure. (Courtesy of Milestone Development Services, Newtown, Pa., USA.)...

The instrumentation presented so far enables scalability in academic and industrial labs from milliliters to approximately 1 L reaction volume or flow rates of several milliliters per minute, respectively. A daily output of some 100 g should be possible with those units. However, industrial users of microwave technology expect solutions for even larger applications as well, dealing with kilogram production per day. Investigations and instrument developments are currently being pursued by most of the instrument vendors. Milestone, for example, already offers two large-scale flow systems (Fig. 13) to close the gap between technical limitations and customer demands [40]. 

Seen from the perspective of recent events, the clinical development of protease inhibitors follows rather conventional programs for drug development. The most remarkable characteristic of the clinical development of HIV-1 protease inhibitors is their rapid clinical evaluation, regulatory approval, and subsequent incorporation into standard treatment regimens. Undoubtedly, the pressure to develop new and active compounds to treat persons with HTV infection contributed to the urgency of drug development. This section will review the clinical milestones for HIV-1 protease inhibitors and discuss some of the near future clinical directions for these compounds. Peer-reviewed, published manuscripts are the basis for this review. Data presented at meetings and published in abstracts were not used. 

The discovery that chiral Lewis acids can catalyze the asymmetric Diels-Alder reaction is a major milestone for the scale up and practice of this reaction on an industrial scale. The use of such a catalyst obviates the need for a chiral auxiliary on the diene or dienophile. The vast majority of chiral auxiliaries that have been used in the Diels-Alder reaction are either not commercially available or are expensive. In addition, the chemical steps needed to attach and remove the chiral auxiliary increase the cost and complexity of the synthesis. Chiral catalysts may also be recovered or recycled, further decreasing cost.47 Research in this area is very active, and catalysts based on a number of metals (Table 26.1) have shown encouraging asymmetric induction.21 Our understanding of the role these catalysts play in the asymmetric induction of Diels-Alder reactions is increasing, and more general reagents should appear. 27-48 54... 

We thank Neil Milestone for helpful and constructive comments. References... 

The child had had a normal and uneventful prenatal and birth history. He was born after a full-term gestation and weighed 3 3 kg. Until a few days prior to the incident, he had no medical problems. His weight, length, and head circumference had always followed the 40th percentile on growth charts. He had attained normal developmental milestones for age.There was no known consanguinity between the parents and no family history of similar problems, and there was a normal 3-year-old brother. 

Among the first cell viability assays developed for HTS was the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] tetrazolium reduction assay (Mosmann 1983) that served as a milestone for this type of study. The assay offered a non-radioactive alternative to tritiated thymidine incorporation into DNA as a method of measuring cell proliferation. In many cases, the MTT assay can directly substitute for the tritiated thymidine incorporation assay (Figure 6.3). The MTT tetrazolium compound is prepared in a physiologically balanced solution, added to cells in culture, and incubated for approximately 4 hr. Viable cells convert MTT into an intensely colored formazan product that can be quantitated by recording changes in absorbance at specific wavelengths. 

Given the current state of knowledge with respect to fuel cell durability, on-board storage systems, and existing component costs, the committee believes that the near-term DOE milestones for FCVs are unrealistically aggressive. 

Product profiles frequently tend to describe an ideal or almost ideal product, because this is much easier and less controversial to define. In order to become a meaningful base for planning and decision making, the essential product characteristics in a product profile should be described as minimum criteria which define what must be achieved and where the product must not fall short. Only minimum criteria are useful to define potential milestones for the development plan which in turn are used as an objective guide for decisions to continue a project or to abandon it, if the milestones cannot be achieved. Desirable goals for further improvements can be added where appropriate. 

---